Gx Acquisiton Corp Cl A (GXGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GXGX | AZN | AMGN | GILD | BMY |
| Company | Gx Acquisiton Corp Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 8.18 | 182.71 | 329.48 | 130.00 | 56.33 |
| High | 12.58 | 183.55 | 332.33 | 133.34 | 56.54 |
| Low | 8.07 | 181.58 | 328.00 | 129.00 | 55.78 |
| Latest | 10.20 | 182.85 | 331.70 | 131.33 | 56.16 |
| Change | +2.18 | +0.33 | +2.61 | -2.73 | -0.09 |
| % Change | +27.18% | +0.18% | +0.79% | -2.04% | -0.16% |
| Volume | 17,319,200 | 1,910,400 | 2,443,200 | 10,250,300 | 10,033,000 |
| 20-Day Average Volume | 1,188,490 | 2,094,690 | 2,669,270 | 6,074,505 | 10,272,725 |
| Previous Close | 8.02 | 182.52 | 329.09 | 134.06 | 56.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.00 | 191.65 | 341.35 | 133.89 | 58.20 |
| 20-Day Raw Stochastic | 50.93% | 11.26% | 30.73% | 26.82% | 11.32% |
| 20-Day Relative Strength | 52.40 | 39.85 | 41.71 | 42.45 | 42.65 |
| Weighted Alpha | -0.69 | +27.43 | +18.80 | +27.28 | +20.31 |
| Today's Opinion | 56% Sell | 8% Sell | 8% Sell | 8% Sell | 24% Buy |
| Previous Opinion | 100% Sell | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 8% Sell | 88% Buy | 56% Buy | 56% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.10% since 07/09/21 | -1.02% since 05/01/26 | +0.57% since 05/01/26 | -0.24% since 05/01/26 | -3.54% since 05/01/26 |
| Low | 7.73 on 07/15/21 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 129.00 on 05/08/26 | 55.57 on 05/07/26 |
| High | 12.58 on 07/16/21 | 185.61 on 05/06/26 | 332.98 on 05/06/26 | 136.75 on 05/06/26 | 58.00 on 05/04/26 |
| 1-Month | |||||
| %Chg | +0.29% since 06/16/21 | -10.49% since 04/08/26 | -5.18% since 04/08/26 | -7.21% since 04/08/26 | -5.14% since 04/08/26 |
| Low | 7.73 on 07/15/21 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 12.58 on 07/16/21 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +0.99% since 04/16/21 | -5.27% since 02/06/26 | -13.69% since 02/06/26 | -13.88% since 02/06/26 | -9.40% since 02/06/26 |
| Low | 7.73 on 07/15/21 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 12.58 on 07/16/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -2.86% since 01/15/21 | +8.09% since 11/07/25 | +3.59% since 11/07/25 | +10.51% since 11/07/25 | +20.28% since 11/07/25 |
| Low | 7.73 on 07/15/21 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 12.58 on 07/16/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 366,557 | 283,071,712 | 177,604,944 | 166,398,224 | 114,866,496 |
| Shares Outstanding, K | 35,937 | 1,550,908 | 539,685 | 1,241,222 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -2,630,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 38,028,962 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.17 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 01/01/70 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.97 | 14.98 | 16.72 | 9.54 |